Mirae Asset Global ETFs Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Buy
42,638
+1,337
+3% +$496K 0.02% 542
2026
Q1
$12.1M Buy
41,301
+783
+2% +$257K 0.02% 602
2025
Q4
$14.2M Sell
40,518
-11,151
-22% -$3.77M 0.02% 540
2025
Q3
$16.7M Buy
51,669
+9,298
+22% +$2.89M 0.03% 495
2025
Q2
$16.5M Buy
42,371
+2,012
+5% +$809K 0.03% 443
2025
Q1
$17.6M Buy
40,359
+544
+1% +$218K 0.04% 422
2024
Q4
$14.7M Buy
39,815
+2,991
+8% +$1.25M 0.03% 459
2024
Q3
$19.1M Sell
36,824
-1,199
-3% -$641K 0.04% 377
2024
Q2
$20.6M Buy
+38,023
New +$20.1M 0.05% 346

Other funds holding ELV

Mirae Asset Global ETFs Holdings's ELV Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Elevance Health (ELV) stake by 3.2% in Q2 2026, buying an estimated $496K and bringing the position to 42,638 shares worth $16.5M. The position accounts for 0.02% of the portfolio, ranked #542.

Mirae Asset Global ETFs Holdings first reported a position in ELV in Q2 2024 and has held it in 9 quarters since. The position peaked at $20.6M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 42,638 shares of Elevance Health worth $16.5M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,337 Elevance Health shares in Q2 2026, an estimated $496K.
  • Elevance Health made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #542 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Elevance Health in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Elevance Health position peaked at $20.6M in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.